| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 49.112 | 51.476 | 58.659 | 93.209 | 97.607 | 73.793 | 75.128 | 35.494 | 5.182 | 0 |
| Total Income - EUR | 49.168 | 51.476 | 66.702 | 85.786 | 98.119 | 76.403 | 75.357 | 46.805 | 5.745 | 49.927 |
| Total Expenses - EUR | 43.400 | 47.152 | 60.462 | 78.883 | 95.612 | 75.257 | 72.528 | 45.635 | 23.482 | 80.801 |
| Gross Profit/Loss - EUR | 5.768 | 4.324 | 6.240 | 6.903 | 2.507 | 1.146 | 2.829 | 1.171 | -17.737 | -30.874 |
| Net Profit/Loss - EUR | 4.293 | 3.809 | 5.416 | 6.046 | 1.547 | 455 | 2.090 | 770 | -17.794 | -31.474 |
| Employees | 4 | 5 | 5 | 6 | 6 | 6 | 5 | 1 | 1 | 1 |
Check the financial reports for the company - Vegameda Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 591 | 312 | 23.222 | 17.155 | 17.689 | 11.201 | 6.647 | 75.304 | 73.431 | 5.134 |
| Current Assets | 5.376 | 3.410 | 4.575 | 8.144 | 7.646 | 12.401 | 10.656 | 39.319 | 34.159 | 18.460 |
| Inventories | 2.335 | 1.756 | 2.229 | 3.115 | 3.577 | 4.524 | 4.106 | 21.439 | 21.545 | 11.373 |
| Receivables | 1.265 | 1.616 | 2.282 | 1.885 | 3.806 | 4.886 | 6.348 | 17.729 | 6.476 | 6.439 |
| Cash | 1.775 | 37 | 64 | 3.144 | 263 | 2.992 | 202 | 151 | 6.138 | 648 |
| Shareholders Funds | -7.398 | -3.514 | 1.962 | 7.972 | 9.364 | 9.641 | 11.517 | 12.323 | -5.508 | -36.951 |
| Social Capital | 90 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 16.739 | 10.575 | 29.119 | 17.328 | 15.972 | 13.961 | 5.785 | 99.043 | 109.851 | 57.316 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.257 | 3.247 | 3.229 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4532 - 4532" | |||||||||
| CAEN Financial Year |
4532
|
|||||||||
Comments - Vegameda Srl